Research progress of coagulation factor Ⅶ and its receptor in tumor targeting therapy

Shenglai Liu,Yu Zhang,Changli Wu
DOI: https://doi.org/10.3969/j.issn.1672-4992.2018.11.038
2018-01-01
Journal of Modern Oncology
Abstract:The specific combination of activated coagulation factor Ⅶ(FⅦ)and tissue factor(TF)acts as an im-portant physiological process of high efficient target recognition for the formation of blood clot.Recently,it is reported that TF presents in solid cancer and influences cytoskeleton reorganization and promotes migration.Not just that,TF is highly expressed by cancer stem cell,TF -targeting therapeutics can effectively eradicate cancer stem cell without drug resistance.Thus,FⅦ is supposed to be a potential contributing factor by gene modification in tumor targeting therapy.This review will discuss the new research progress of FⅦ and its receptor TF in tumor targeting therapy.
What problem does this paper attempt to address?